Literature DB >> 25224549

Ventriculovascular interactions late after atrial and arterial repair of transposition of the great arteries.

Giovanni Biglino1, Hopewell Ntsinjana2, Carla Plymen3, Oliver Tann3, Alessandro Giardini3, Graham Derrick3, Kim H Parker4, Victor Tsang3, Silvia Schievano2, Andrew M Taylor2.   

Abstract

OBJECTIVE: The aim of this study was to compare atrial switch and arterial switch operations for the repair of transposition of the great arteries (TGA), assessing cardiac function and ventriculoarterial (VA) coupling based on cardiac magnetic resonance (CMR) data. Using CMR-derived wave intensity analysis, this study provides a noninvasive comparison of the 2 systemic ventricles and evaluates the subclinical hemodynamic burden of these operations.
METHODS: Fifty-four patients (18 controls, 18 atrial switches, 18 arterial switches) were studied. Dimensional and functional data, including the ejection fraction (EF) and end-diastolic volume, were derived from CMR, as well as aortic distensibility. Wave intensity was computed from CMR according to a formulation based on changes in area and velocity, and the peaks of the 2 major systolic waves (forward compression wave [FCW], and forward expansion wave [FEW]) were measured as indicators of ventricular function.
RESULTS: Both switches exhibited significantly increased end-diastolic volume and enlarged aortic root areas, and atrial switches were also characterized by significantly lower EF. Patients with TGA presented stiffer ascending aortas, particularly those repaired with an arterial switch. Both FCW and FEW were significantly lower in both TGA cohorts than the controls, suggesting compromised VA coupling, likely a result of increased impedance caused by the stiffer ascending aorta. A significant difference between switch type was noticed in terms of the FEW peak, which was lower in the atrial switch group.
CONCLUSIONS: These data highlight reduced aortic distensibility and abnormal VA coupling in repaired TGA. An intraoperational difference was noted in terms of EF and peak FEW, likely reflecting the different nature of the subaortic ventricle.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25224549     DOI: 10.1016/j.jtcvs.2014.07.072

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Peripheral Endothelial Function After Arterial Switch Operation for D-looped Transposition of the Great Arteries.

Authors:  Heather Y Sun; Katie Jo Stauffer; Susan E Nourse; Chau Vu; Elif Seda Selamet Tierney
Journal:  Pediatr Cardiol       Date:  2017-03-27       Impact factor: 1.655

2.  Circulating Transforming Growth Factor-β and Aortic Dilation in Patients with Repaired Congenital Heart Disease.

Authors:  Yiu-Fai Cheung; Pak-Cheong Chow; Edwina Kam-Fung So; Koon-Wing Chan
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

3.  Feasibility of Wave Intensity Analysis in Patients With Conotruncal Anomalies Before and After Pregnancy: New Physiological Insights?

Authors:  Maria Victoria Ordonez; Sandra Neumann; Massimo Caputo; Stephanie Curtis; Giovanni Biglino
Journal:  Front Pediatr       Date:  2021-03-04       Impact factor: 3.418

4.  Feasibility of cardiovascular magnetic resonance derived coronary wave intensity analysis.

Authors:  Claire E Raphael; Jennifer Keegan; Kim H Parker; Robin Simpson; Julian Collinson; Vass Vassiliou; Ricardo Wage; Peter Drivas; Stephen Strain; Robert Cooper; Ranil de Silva; Rod H Stables; Carlo Di Mario; Michael Frenneaux; Dudley J Pennell; Justin E Davies; Alun D Hughes; David Firmin; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2016-12-09       Impact factor: 5.364

5.  Non-physiological Aortic Flow and Aortopathy in Adult Patients with Transposition of the Great Arteries after the Jatene Procedure: A Pilot Study Using Echo Planar 4D Flow MRI.

Authors:  Yumi Shiina; Kei Inai; Michinobu Nagao
Journal:  Magn Reson Med Sci       Date:  2021-02-06       Impact factor: 2.471

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.